The role of sphingosine-1 phosphate and ceramide-1 phosphate in trafficking of normal stem cells and cancer cells

Introduction: A common feature of many types of cells is their responsiveness to chemotactic gradients of factors for which they express the corresponding receptors. The most studied chemoattractants so far are peptide-based growth factors and a family of cytokines endowed with strong chemotactic properties, called chemokines. However, additional evidence has accumulated that, in addition to these peptide-based chemoattractants, an important role in cell migration is played by bioactive lipids. Areas covered: Solid evidence has accumulated that two bioactive phosphorylated sphingolipids that are derivatives of sphingolipid metabolism, namely sphingosine-1-phosphate (S1P) and ceramide-1-phosphate (C1P), are potent chemoattractants for a variety of cells. In this review, we will discuss the effect of these two phosphorylated sphingolipids on the trafficking of normal and malignant cells, and, in particular, we will focus on their role in trafficking of normal hematopoietic stem/progenitor cells. Unlike other mediators, S1P under steady-state conditions maintain a steep gradient between interstitial fluid and peripheral blood and lymph across the endothelial barrier, which is important in the egress of cells from bone marrow. Both S1P and C1P may be upregulated in damaged tissues, which may result in reversal of this gradient. Expert opinion: S1P and C1P are important regulators of the trafficking of normal and malignant cells, and modification of their biological effects will have important applications in optimizing stem cell mobilization and homing, tissue organ/regeneration, and preventing cancer metastasis.

[1]  B. Brüne,et al.  Apoptotic cells enhance sphingosine‐1‐phosphate receptor 1 dependent macrophage migration , 2013, European journal of immunology.

[2]  Junlin Qi,et al.  Increased sphingosine-1-phosphate improves muscle regeneration in acutely injured mdx mice , 2013, Skeletal Muscle.

[3]  L. Bendall,et al.  Role of sphingosine 1-phosphate in trafficking and mobilization of hematopoietic stem cells , 2013, Current opinion in hematology.

[4]  M. Ratajczak,et al.  An emerging link in stem cell mobilization between activation of the complement cascade and the chemotactic gradient of sphingosine-1-phosphate. , 2013, Prostaglandins & other lipid mediators.

[5]  L. Malinina,et al.  Nonvesicular trafficking by a ceramide-1-phosphate transfer protein regulates eicosanoids , 2013, Nature.

[6]  R. Stevens,et al.  Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. , 2013, Annual review of biochemistry.

[7]  A. Gomez-Muñoz,et al.  Ceramide 1-phosphate induces macrophage chemoattractant protein-1 release: involvement in ceramide 1-phosphate-stimulated cell migration. , 2013, American journal of physiology. Endocrinology and metabolism.

[8]  A. Gomez-Muñoz,et al.  New insights on the role of ceramide 1-phosphate in inflammation. , 2013, Biochimica et biophysica acta.

[9]  M. Ratajczak,et al.  Bioactive lipids and cationic antimicrobial peptides as new potential regulators for trafficking of bone marrow-derived stem cells in patients with acute myocardial infarction. , 2013, Stem cells and development.

[10]  P. Houghton,et al.  Bioactive Lipids S1P and C1P Are Prometastatic Factors in Human Rhabdomyosarcoma, and Their Tissue Levels Increase in Response to Radio/Chemotherapy , 2013, Molecular Cancer Research.

[11]  M. Ratajczak,et al.  Ceramide‐1‐Phosphate Regulates Migration of Multipotent Stromal Cells and Endothelial Progenitor Cells—Implications for Tissue Regeneration , 2013, Stem cells.

[12]  M. Ratajczak,et al.  Innate Immunity Derived Factors as External Modulators of the CXCL12 - CXCR4 Axis and Their Role in Stem Cell Homing and Mobilization , 2013, Theranostics.

[13]  S. Khosla,et al.  Sphingosine 1-Phosphate (S1P) Receptors 1 and 2 Coordinately Induce Mesenchymal Cell Migration through S1P Activation of Complementary Kinase Pathways* , 2013, The Journal of Biological Chemistry.

[14]  Jaesik Park,et al.  FTY720 preserved islet β‐cell mass by inhibiting apoptosis and increasing survival of β‐cells in db/db mice , 2013, Diabetes/metabolism research and reviews.

[15]  M. Ratajczak,et al.  Novel Evidence That Hematopoietic Stem/Progenitor Cells (HSPCs) Are Mobilized During Hemolysis in an Erythrocyte Lysis-Derived, Sphingosine-1-Phosphate (S1P)-Dependent manner—the Crucial Involvement of Complement Cascade (CC) Activation and Attenuation of CXCR4 Retention Signaling , 2012 .

[16]  T. Hla,et al.  Fine-tuning S1P therapeutics. , 2012, Chemistry & biology.

[17]  N. Baldini,et al.  Mesenchymal stem cell secreted vesicles provide novel opportunities in (stem) cell-free therapy , 2012, Front. Physio..

[18]  J. Maciejewski,et al.  A novel view of paroxysmal nocturnal hemoglobinuria pathogenesis: more motile PNH hematopoietic stem/progenitor cells displace normal HSPCs from their niches in bone marrow due to defective adhesion, enhanced migration and mobilization in response to erythrocyte-released sphingosine-1 phosphate grad , 2012, Leukemia.

[19]  M. Ratajczak,et al.  S1P promotes murine progenitor cell egress and mobilization via S1P1-mediated ROS signaling and SDF-1 release. , 2012, Blood.

[20]  A. Gomez-Muñoz,et al.  Ceramide 1-phosphate stimulates proliferation of C2C12 myoblasts , 2012, Biochimie.

[21]  P. Gonzalez-Cabrera,et al.  S1P1 Receptor Modulation with Cyclical Recovery from Lymphopenia Ameliorates Mouse Model of Multiple Sclerosis , 2012, Molecular Pharmacology.

[22]  Xianghuo He,et al.  Sphingosine kinase 1 promotes tumour cell migration and invasion via the S1P/EDG1 axis in hepatocellular carcinoma , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[23]  J. Dipersio,et al.  Sphingosine-1-phosphate facilitates trafficking of hematopoietic stem cells and their mobilization by CXCR4 antagonists in mice. , 2012, Blood.

[24]  R. Charnigo,et al.  Plasma levels of sphingosine 1-phosphate are strongly correlated with haematocrit, but variably restored by red blood cell transfusions , 2011, Clinical science.

[25]  A. Moon,et al.  Sphingosine 1-phosphate regulates matrix metalloproteinase-9 expression and breast cell invasion through S1P3–Gαq coupling , 2011, Journal of Cell Science.

[26]  M. Ratajczak,et al.  CONDITIONING FOR HEMATOPOIETIC TRANSPLANTATION ACTIVATES THE COMPLEMENT CASCADE AND INDUCES A PROTEOLYTIC ENVIRONMENT IN BONE MARROW – A NOVEL ROLE FOR BIOACTIVE LIPIDS AND SOLUBLE C5b-C9 AS HOMING FACTORS , 2011, Leukemia.

[27]  M. Ratajczak The emerging role of microvesicles in cellular therapies for organ/tissue regeneration. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[28]  Dong-Myung Shin,et al.  The role of pluripotent embryonic-like stem cells residing in adult tissues in regeneration and longevity. , 2011, Differentiation; research in biological diversity.

[29]  A. Borowsky,et al.  S1P lyase: a novel therapeutic target for ischemia-reperfusion injury of the heart. , 2011, American journal of physiology. Heart and circulatory physiology.

[30]  D. Link,et al.  Mechanisms of G-CSF-mediated hematopoietic stem and progenitor mobilization , 2011, Leukemia.

[31]  M. Lee,et al.  To stay or to leave: Stem cells and progenitor cells navigating the S1P gradient. , 2011, World journal of biological chemistry.

[32]  M. Tendera,et al.  Circulating Very Small Embryonic-Like Stem Cells in Cardiovascular Disease , 2010, Journal of cardiovascular translational research.

[33]  M. Ishii,et al.  Chemorepulsion by blood S1P regulates osteoclast precursor mobilization and bone remodeling in vivo , 2010, The Journal of experimental medicine.

[34]  A. Bielawska,et al.  Blood sphingolipidomics in healthy humans: impact of sample collection methodology , 2010, Journal of Lipid Research.

[35]  Caiying Guo,et al.  Cell-surface residence of sphingosine 1-phosphate receptor 1 on lymphocytes determines lymphocyte egress kinetics , 2010, The Journal of experimental medicine.

[36]  H. Fyrst,et al.  An update on sphingosine-1-phosphate and other sphingolipid mediators. , 2010, Nature chemical biology.

[37]  S. Pyne,et al.  Sphingosine 1-phosphate and cancer , 2010, Nature Reviews Cancer.

[38]  J. Saba,et al.  S1P metabolism in cancer and other pathological conditions. , 2010, Biochimie.

[39]  F. Thol,et al.  Erythrocytes serve as a reservoir for cellular and extracellular sphingosine 1‐phosphate , 2010, Journal of cellular biochemistry.

[40]  M. Ratajczak,et al.  PLASMA SPHINGOSINE 1-PHOSPHATE IS A MAJOR CHEMOATTRACTANT THAT DIRECTS EGRESS OF HEMATOPOIETIC STEM PROGENITOR CELLS FROM BONE MARROW AND ITS LEVEL IN PERIPHERAL BLOOD INCREASES DURING MOBILIZATION DUE TO ACTIVATION OF COMPLEMENT CASCADE/MEMBRANE ATTACK COMPLEX , 2010, Leukemia.

[41]  Ludwig Kappos,et al.  Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis. , 2010, The New England journal of medicine.

[42]  M. Hiraiwa,et al.  Production and characterization of monoclonal anti-sphingosine-1-phosphate antibodies1 , 2009, Journal of Lipid Research.

[43]  G. Camussi,et al.  Human liver stem cell-derived microvesicles accelerate hepatic regeneration in hepatectomized rats , 2009, Journal of cellular and molecular medicine.

[44]  T. Blom,et al.  Sphingosine kinase as an oncogene: autocrine sphingosine 1-phosphate modulates ML-1 thyroid carcinoma cell migration by a mechanism dependent on protein kinase C-alpha and ERK1/2. , 2009, Endocrinology.

[45]  F. Bornancin,et al.  Ceramide kinase deficiency impairs microendothelial cell angiogenesis in vitro. , 2009, Microvascular research.

[46]  T. Hla,et al.  S1P/S1P1 signaling stimulates cell migration and invasion in Wilms tumor. , 2009, Cancer letters.

[47]  D. Brindley,et al.  Lipid phosphate phosphatases and signaling The work was supported by the Canadian Institutes of Health Research. Published, JLR Papers in Press, December 9, 2008. , 2009, Journal of Lipid Research.

[48]  A. Gomez-Muñoz,et al.  Ceramide 1-phosphate (C1P) promotes cell migration Involvement of a specific C1P receptor. , 2009, Cellular signalling.

[49]  T. Ohmori,et al.  Antagonism of Sphingosine 1-Phosphate Receptor-2 Enhances Migration of Neural Progenitor Cells Toward an Area of Brain Infarction , 2008, Stroke.

[50]  R. Proia,et al.  The alliance of sphingosine-1-phosphate and its receptors in immunity , 2008, Nature Reviews Immunology.

[51]  T. Hla,et al.  The vascular S1P gradient-cellular sources and biological significance. , 2008, Biochimica et biophysica acta.

[52]  Yong Song Gho,et al.  Sphingosine-1-phosphate promotes lymphangiogenesis by stimulating S1P1/Gi/PLC/Ca2+ signaling pathways. , 2008, Blood.

[53]  B. Kinzel,et al.  Wild-type levels of ceramide and ceramide-1-phosphate in the retina of ceramide kinase-like-deficient mice. , 2008, Biochemical and biophysical research communications.

[54]  M. Gladwin,et al.  Chronic Hyper-Hemolysis in Sickle Cell Anemia: Association of Vascular Complications and Mortality with Less Frequent Vasoocclusive Pain , 2008, PloS one.

[55]  H. Bonkovsky,et al.  Vascular Endothelium As a Contributor of Plasma Sphingosine 1-Phosphate , 2008, Circulation research.

[56]  P. V. Van Veldhoven,et al.  Neutropenia with Impaired Immune Response to Streptococcus pneumoniae in Ceramide Kinase-Deficient Mice , 2008, The Journal of Immunology.

[57]  Yusuf A. Hannun,et al.  Principles of bioactive lipid signalling: lessons from sphingolipids , 2008, Nature Reviews Molecular Cell Biology.

[58]  Yannick Jacques,et al.  Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor , 2007, Nature Immunology.

[59]  Ulrich H. von Andrian,et al.  Immunosurveillance by Hematopoietic Progenitor Cells Trafficking through Blood, Lymph, and Peripheral Tissues , 2007, Cell.

[60]  V. Brinkmann Sphingosine 1-phosphate receptors in health and disease: mechanistic insights from gene deletion studies and reverse pharmacology. , 2007, Pharmacology & therapeutics.

[61]  J. Cyster,et al.  Promotion of Lymphocyte Egress into Blood and Lymph by Distinct Sources of Sphingosine-1-Phosphate , 2007, Science.

[62]  P. Zoltick,et al.  CD26 inhibition enhances allogeneic donor-cell homing and engraftment after in utero hematopoietic-cell transplantation. , 2006, Blood.

[63]  J Ratajczak,et al.  Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication , 2006, Leukemia.

[64]  Yiling Lu,et al.  Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. , 2006, Cancer cell.

[65]  Alejandro Erices,et al.  Mesenchymal Stem Cells and the Treatment of Cardiac Disease , 2005 .

[66]  R. Proia,et al.  Essential Role for Sphingosine Kinases in Neural and Vascular Development , 2005, Molecular and Cellular Biology.

[67]  C. Chalfant,et al.  Ceramide-1-phosphate: the "missing" link in eicosanoid biosynthesis and inflammation. , 2005, Molecular interventions.

[68]  K. Chiba FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors. , 2005, Pharmacology & therapeutics.

[69]  S. Spiegel,et al.  Sphingosine 1-phosphate and ceramide 1-phosphate: expanding roles in cell signaling , 2005, Journal of Cell Science.

[70]  S. Pyne,et al.  Regulation of cell survival by lipid phosphate phosphatases involves the modulation of intracellular phosphatidic acid and sphingosine 1-phosphate pools. , 2005, The Biochemical journal.

[71]  Ying Xu,et al.  Lymphocyte Sequestration Through S1P Lyase Inhibition and Disruption of S1P Gradients , 2005, Science.

[72]  T. Hla Dietary Factors and Immunological Consequences , 2005, Science.

[73]  R. Förster,et al.  Sphingosine-1-Phosphate Mediates Migration of Mature Dendritic Cells1 , 2005, The Journal of Immunology.

[74]  D. Zaller,et al.  Sphingosine 1‐phosphate receptor agonist FTY720‐phosphate causes marginal zone B cell displacement , 2005, Journal of leukocyte biology.

[75]  A. Parrill,et al.  S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. , 2005, Chemistry & biology.

[76]  G. Seitz,et al.  The Role of Sphingosine 1‐Phosphate Receptors in the Trafficking of Hematopoietic Progenitor Cells , 2005, Annals of the New York Academy of Sciences.

[77]  F. Bernardi,et al.  Circadian Rhythms in Mouse Blood Coagulation , 2005, Journal of biological rhythms.

[78]  Michael D. Davis,et al.  Sphingosine 1-Phosphate Analogs as Receptor Antagonists* , 2005, Journal of Biological Chemistry.

[79]  R. Proia,et al.  The Sphingosine-1-phosphate Receptors S1P1, S1P2, and S1P3 Function Coordinately during Embryonic Angiogenesis* , 2004, Journal of Biological Chemistry.

[80]  J. Cyster,et al.  FTY720: Sphingosine 1‐Phosphate Receptor‐1 in the Control of Lymphocyte Egress and Endothelial Barrier Function , 2004, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[81]  G. Seitz,et al.  The sphingosine 1-phosphate receptor agonist FTY720 supports CXCR4-dependent migration and bone marrow homing of human CD34+ progenitor cells. , 2004, Blood.

[82]  P. Houghton,et al.  Both hepatocyte growth factor (HGF) and stromal-derived factor-1 regulate the metastatic behavior of human rhabdomyosarcoma cells, but only HGF enhances their resistance to radiochemotherapy. , 2003, Cancer research.

[83]  Naftali Kaminski,et al.  Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[84]  M. Tanimoto,et al.  Plasma stromal cell-derived factor-1 during granulocyte colony-stimulating factor-induced peripheral blood stem cell mobilization , 2003, Bone Marrow Transplantation.

[85]  R. Discipio,et al.  Complement C3a and C5a Induce Different Signal Transduction Cascades in Endothelial Cells1 , 2002, The Journal of Immunology.

[86]  James R. Van Brocklyn,et al.  Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase β , 2002 .

[87]  J. Chun,et al.  Marked Perinatal Lethality and Cellular Signaling Deficits in Mice Null for the Two Sphingosine 1-Phosphate (S1P) Receptors, S1P2/LPB2/EDG-5 and S1P3/LPB3/EDG-3* , 2002, The Journal of Biological Chemistry.

[88]  R. Taichman,et al.  G-CSF induces stem cell mobilization by decreasing bone marrow SDF-1 and up-regulating CXCR4 , 2002, Nature Immunology.

[89]  A. Morris,et al.  Roles for lipid phosphate phosphatases in regulation of cellular signaling. , 2002, Biochimica et biophysica acta.

[90]  B. Friedman,et al.  Selective Loss of Sphingosine 1-Phosphate Signaling with No Obvious Phenotypic Abnormality in Mice Lacking Its G Protein-coupled Receptor, LPB3/EDG-3* , 2001, The Journal of Biological Chemistry.

[91]  J. P. Hobson,et al.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.

[92]  Y. Yanagawa,et al.  FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L‐positive T cells in Peyer’s patches by FTY720‐induced lymphocyte homing , 1998, Immunology.

[93]  D. Brindley,et al.  Mammalian Lipid Phosphate Phosphohydrolases* , 1998, The Journal of Biological Chemistry.

[94]  H. Kataoka,et al.  FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. , 1998, Journal of immunology.

[95]  Y. Igarashi,et al.  Sphingosine 1-phosphate, a bioactive sphingolipid abundantly stored in platelets, is a normal constituent of human plasma and serum. , 1997, Journal of biochemistry.

[96]  T. Springer,et al.  The Chemokine SDF-1 Is a Chemoattractant for Human CD34+ Hematopoietic Progenitor Cells and Provides a New Mechanism to Explain the Mobilization of CD34+ Progenitors to Peripheral Blood , 1997, The Journal of experimental medicine.

[97]  A. Gomez-Muñoz,et al.  Short-chain ceramide-1-phosphates are novel stimulators of DNA synthesis and cell division: antagonism by cell-permeable ceramides. , 1995, Molecular pharmacology.

[98]  M. Pallansch,et al.  Circadian and circannual aspects of the complement cascade - new and old results, differing in specificity. , 1980, Chronobiologia.

[99]  C. McCall,et al.  The effect of cobra venom factor (CVF) activation of the complement cascade on leukocyte circadian variation in the rat , 1977, Experientia.

[100]  M. Ratajczak,et al.  A novel perspective on stem cell homing and mobilization: review on bioactive lipids as potent chemoattractants and cationic peptides as underappreciated modulators of responsiveness to SDF-1 gradients , 2012, Leukemia.

[101]  T. Hla,et al.  Sphingosine 1-phosphate in coagulation and inflammation , 2011, Seminars in Immunopathology.

[102]  G. Francis,et al.  Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis , 2010, Nature Reviews Drug Discovery.

[103]  H. Nagawa,et al.  Sphingosine 1-phosphate receptor expression profile in human gastric cancer cells: differential regulation on the migration and proliferation. , 2006, The Journal of surgical research.

[104]  H. Nagawa,et al.  Sphingosine 1-Phosphate Receptor Expression Profile in Human Gastric Cancer Cells: Differential Regulation on the Migration and Proliferation1 , 2006 .

[105]  T. Prior,et al.  Sphingosine-1-phosphate stimulates human glioma cell proliferation through Gi-coupled receptors: role of ERK MAP kinase and phosphatidylinositol 3-kinase beta. , 2002, Cancer letters.